Shelby Newsad
Investor at Compound
United States
Overview
Work Experience
Investor
2022 - Current
Compound is a thesis-driven, research-centric investment firm
PhD Candidate Plant Science
2018 - 2022
· Working with synthetic biology techniques to investigate vitamin-repressible systems · Exploiting synthetic ecology to study microbial-algae vitamin dependence via “-omics approaches” and mutageneses · Cambridge Trust/Newnham Graduate Research Scholar
MPhil Candidate in Bioscience Enterprise
2017 - 2020
· Class President · Cambridge Consulting Network: Strategy consulting for biotechnology AI start-up · EnterpriseTECH consulting: Consultant for biotechnology start-up through Enterprise Center at Judge Business School
Analyst
2021 - 2022
Team Lead Due Diligence Projects
2020 - 2021
· Organise, co-ordinate, and lead a group of 4 students in conducting due diligence for early-stage healthcare start-ups · ~1 deep diligence of company per week · Liaise directly with CEO of Start Codon regarding recommendation for further due diligence
Summer Intern
2020 - 2020
· Conducted landscape analysis reporting industry trends and potential investment opportunities to Senior Associate and team (including the Managing Partner) · Completed scientific due diligence on potential investment opportunities, including patent and literature searches · Participated in contacting and liaising with potential investment opportunities
Founder and President
2019 - 2020
Leader of Tomorrow
2019 - 2020
President
2018 - 2019
Initiator of Due Diligence Projects and "Breaking into Investing" speaker and case-study series which: · Gives students hand-on experience to the due diligence process in venture capital · Brings unparalleled networking opportunities to Cambridge University students in the field of biotechnology and technology investing · Provides a learning environment where investing case-studies are taught by experts
Consultant
2018 - 2018
Provided strategy consulting advice to Cambridge-based AI drug discovery start up regarding: · Data acquisition companies to train AI algorithm · Most attractive pharmaceutical partners
Foresight & Scouting
2018 - 2018
· Developed an investment proposal which was assessed and funded by the board of Merck · Reported to the innovation field leader and CIO · Contributed to strategy meetings with a task to identify market openings in the Innovation Center: New Business Builder Team.